USD 17.67 bn Growth in Injection Pen Market Size | AstraZeneca Plc and Becton Dickinson and Co. Among Key Vendors | Technavio – PRNewswire

The injection pen market witnessed maximum growth in the growth hormone product segment in 2020. Based on geography, North America occupied about 44% of the market share in 2020. The growth of the market in North America can be attributed to factors such as the increasing incidence of diabetes.

Injection Pen Market: Major Growth Drivers

The injection pen market report the following factors as major growth drivers during the forecast period:

Request a Free Sample Report Nowfor more information on the trends, drivers, and challenges impacting the market

Injection Pen Market: Key Vendor Offerings

Reasons to Buy Injection Pen Market Report:

Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!

Related Reports:

Injection Pen Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Decelerate at a CAGR of 7.40%

Market growth 2021-2025

USD 17.67 billion

Market structure

Fragmented

YoY growth (%)

10.33

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 44%

Key consumer countries

US, China, Canada, Germany, and UK

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

AstraZeneca Plc, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Sanofi SA, and Ypsomed Holding AG

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About UsTechnavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [emailprotected]Website: http://www.technavio.com/

SOURCE Technavio

USD 17.67 bn Growth in Injection Pen Market Size | AstraZeneca Plc and Becton Dickinson and Co. Among Key Vendors | Technavio - PRNewswire